Low-Level Lead Exposure, Intelligence and Academic Achievement:A Long-Term Follow-Up Study
Pediatrics 90:855-861, Bellinger,D.C.,et al, 1992
Neurocognitive Effects of Aluminum
Arch Neurol 49:1021-1026, Bolla,K.I.,et al, 1992
Orthostatic Hypotension in Ciguatera Fish Poisoning
Arch Int Med 152:2131-2133, Geller,R.J.&Banowitz,N.L., 1992
Travel and Ciguatera Fish Poisoning
Arch Int Med 152:2049-2053, Lange,W.R.,et al, 1992
Cognitive Development of Yu-Cheng ('Oil Disease') Children Prenatally Exposed to Heat-Degraded PCBs
JAMA 268:3213-3218, Chen,Y.J.,et al, 1992
Lesions of Basal Ganglia Due to Disulfiram Neurotoxicity
JNNP 55:925-929, Laplane,D.,et al, 1992
Typical Absence Seizures in Adults:Clinical, EEG, Video-EEG Findings & Diagnostic/Syndr Consider
JNNP 55:1002-1008, Panayiotopoulos,C.P.,et al, 1992
Safety and Efficacy of Valproate and Carbamazepine in the Treatment of Complex Partial Seizures
J Epilepsy 5:149-152, So,E.L.,et al, 1992
Delayed Diagnosis of Juvenile Myoclonic Epilepsy
JNNP 55:497-499, Grunewald,R.A.,et al, 1992
Prevention of First Occur of Neural-Tube Defects by Periconceptional Vitamin Suppl
NEJM 327:1832-1835, 18751992., Czeizel,A.E.&Dudas,I., 1992
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Prolonged Seizure Activity after Baclofen Withdrawal
Neurol 42:697-698, Kofler,M.&Leis,A.A., 1992
Unsuspected, Surreptitious Drug-Induced Parkinsonism
Neurol 42:459, Albanese,A.,et al, 1992
Erythromelalgia:Review of Clinical Characteristics and Pathophysiology
Am J Med 91:416-422, Jurzrock,R.&Cohen,P.R., 1991
Migraine-Related Stroke in Childhood
Lancet 337:825-826, , 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Mitochondrial Dysfunction in Multiple Symmetrical Lipomatosis
Ann Neurol 29:566-569, Berkovic,S.F.,et al, 1991
Prevention of Neural Tube Defects:Results of the Medical Research Council Vitamin Study
Lancet 338:131-137, 153-1541991., , 1991
The Effect of Valproic Acid on Plasma Carnitine Levels
Am J Dis Child 145:9999-1001, Opala,G.,et al, 1991
Muscle Carnitine Deficiency in Patients Using Valproic Acid
J Pediatr 118:646-649, Shapira,Y.&Gutman,A., 1991
Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Polymyositis after Ciguatera Toxin Exposure
Arch Neurol 48:874-877, Stommel,E.W.,et al, 1991
Colchicine-Induced Myopathy and Neuropathy
Neurol 41:943, Younger,D.S.,et al, 1991
Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions
JAMA 266:693-695, Keeler,J.R.,et al, 1991
Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991
A Glossary of What is Available
Chemical Weapons, Biological Weapons, USA Today, p. 3A, Feb 8., , 1991
Environmental Risk Factors in Siblings with Parkinson's Disease
Arch Neurol 48:287-289, Wong,G.F.,et al, 1991
Diagnosis and Management of Neural-Tube Defects Today
NEJM 324:690-691, Hobbins,J.C., 1991
Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991
Evidence that Histamine is the Causative Toxin of Scombroid-Fish Poisoning
NEJM 324:716-720, 766-7681991., Morrow,J.D.,et al, 1991
Intrathecal Baclofen for Spasticity in Cerebral Palsy
JAMA 265:1418-1422, Albright,A.L.,et al, 1991
Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991
The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991
Occurrence of Stroke Associated with Use/Abuse of Drugs
Neurol 41:1358-1364, Sloan,M.A.,et al, 1991
Antiphospholipid Antibodies in Cerebral Ischemia
Stroke 22:750-753, Montalban,J.,et al, 1991
Akinetic Mutism after Baclofen
Ann Int Med 115:499-500, Parmar,M.S., 1991
Intrathecal Baclofen for Intractable Axial Dystonia
Neurol 41:1141-1142, Narayan,R.K.,et al, 1991
Screening for Dementia and Investigating Its Causes
Ann Int Med 115:122-132, Siu,A.L., 1991
Magnetic Resonance Imaging in Toxic Encephalopathy Due to Podophyllin Poisoning
Neuroradiology 33:372-373, Chan,Y.W., 1991
A Wernicke's Encephalopathy-Like Neurotoxicity Induced by Erbulozole
Neurol 41:762-763, DeKloppel,N.,et al, 1991